GNH USA

Europe — EMA

Menotrophin Ferring

GNH USA supplies Menotrophin Ferring (Menotrophin), a gonadotropin for infertility due to anovulation and controlled ovarian stimulation.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotrophin, the active ingredient in Menotrophin Ferring, is a gonadotropin (FSH/LH) presented as an injection for subcutaneous use. It stimulates follicular development and ovulation in women with infertility due to anovulation.

GNH USA supplies Menotrophin Ferring as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Menotrophin used for?

Menotrophin is a gonadotropin used in reproductive medicine to induce follicular growth and ovulation. - Infertility due to anovulation: promotes follicular development to enable ovulation. - Controlled ovarian stimulation for assisted reproductive technology (ART): supports multiple follicle growth for IVF cycles. - Ovarian stimulation in intrauterine insemination (IUI) protocols: enhances egg maturation for timed insemination.

What are the side effects of Menotrophin?

Menotrophin may cause a range of adverse reactions, which are generally related to its hormonal activity and injection site.

Common Side Effects: - Injection site pain: mild discomfort at the injection site. - Headache: transient headache of varying intensity. - Nausea: occasional nausea or upset stomach.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS): severe ovarian enlargement with fluid shift. - Thromboembolic events: rare blood clot formation. - Allergic reaction: rash, urticaria, or anaphylaxis.

What precautions apply to Menotrophin?

When using Menotrophin, careful patient assessment and monitoring are essential. - Patient selection: assess for risk of ovarian hyperstimulation before initiating therapy. - Monitoring: perform regular ultrasound and estradiol measurements during stimulation. - Contraindications: avoid in active ovarian cysts, uncontrolled thyroid disease, or estrogen‑dependent tumors. - Pregnancy status: discontinue if pregnancy is confirmed. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menotrophin can interact with other medications that affect hormonal balance or coagulation.

Major Interactions (Avoid): - GnRH agonists/antagonists: concurrent use may cause excessive ovarian response. - Anticoagulants (e.g., warfarin, heparin): increased risk of ovarian hyperstimulation‑related thrombosis. - Aromatase inhibitors: may blunt the estrogenic response needed for follicular development.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: altered metabolism may affect response to gonadotropins. - Corticosteroids: may influence ovarian response and fluid balance. - Insulin or oral hypoglycemics: monitor glucose as hormonal changes can affect glycemic control.

Frequently asked questions

What is Menotrophin Ferring used for?+
Menotrophin Ferring is prescribed to treat infertility caused by anovulation and to support controlled ovarian stimulation in assisted reproductive technologies such as IVF and IUI. By providing both FSH and LH activity, it helps develop mature ovarian follicles and trigger ovulation.
How does Menotrophin work?+
Menotrophin contains analogues of follicle‑stimulating hormone (FSH) and luteinizing hormone (LH). After subcutaneous injection, the FSH component stimulates granulosa cells to recruit and grow ovarian follicles, while the LH component promotes theca cell androgen production and final follicular maturation, culminating in ovulation.
What is the usual dose of Menotrophin?+
The specific dose of Menotrophin is individualized and determined by the prescribing physician based on the patient’s ovarian response, treatment protocol, and clinical goals. Dosing regimens can vary widely, and the prescriber will adjust the amount and duration according to monitoring results.
Is Menotrophin safe in pregnancy or breastfeeding?+
Menotrophin is intended for use before conception to induce ovulation; its safety in established pregnancy has not been established, and it is generally discontinued once pregnancy is confirmed. Limited data exist for use during breastfeeding, so it should be avoided unless the benefits outweigh potential risks as judged by a healthcare professional.
How do I order Menotrophin Ferring from GNH USA?+
To place an order, submit an enquiry on the Menotrophin Ferring product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and required import documentation.
How does Menotrophin compare with other gonadotropin products?+
Menotrophin uniquely combines both FSH and LH activity in a single preparation, whereas many other gonadotropin products contain only FSH or only LH. This dual action can simplify stimulation protocols and may reduce the number of injections required, but the choice between products depends on individual patient characteristics and clinician preference.
How should Menotrophin be stored and handled?+
Menotrophin must be stored refrigerated at 2‑8 °C (36‑46 °F). Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking. If the product must be transported, maintain the cold chain using validated insulated containers and temperature monitors.
How is Menotrophin administered?+
Menotrophin is given by subcutaneous injection, typically into the abdominal wall or thigh. The injection is performed by a trained healthcare professional or a patient who has been instructed on proper aseptic technique, dose preparation, and site rotation to minimize discomfort and local reactions.
What are the most serious risks to watch for when using Menotrophin?+
The most serious risks include ovarian hyperstimulation syndrome (OHSS), which can cause significant ovarian enlargement, fluid shifts, and thromboembolic events, as well as rare allergic reactions such as anaphylaxis. Patients should be monitored closely for abdominal pain, rapid weight gain, shortness of breath, or signs of an allergic response.
Who should not use Menotrophin?+
Menotrophin is contraindicated in women with active ovarian cysts, uncontrolled thyroid disease, estrogen‑dependent tumors, severe liver or kidney impairment, or known hypersensitivity to the product. It should also be avoided in patients who are already pregnant or who have a history of severe OHSS.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Menotrophin
Route
Subcutaneous Use
Manufacturer
Ferring N.V.
Origin
EU

Related products